6874-67-5

Basic information

• Product Name: FARNESYL BROMIDE, 95% (MIXED ISOMERS)
• Synonyms: FARNESYL BROMIDE, 95% (MIXED ISOMERS)
• CAS NO: 6874-67-5
• Molecular Formula: C₁₅H₂₅Br
• Molecular Weight: 285.26
• Mol File: 6874-67-5.mol
• Article Data: 88

Chemical Properties

• Boiling Point: 333.3±21.0 °C(Predicted)
• Appearance: /
• Density: 1.0650 g/cm3
• CAS DataBase Reference: FARNESYL BROMIDE, 95% (MIXED ISOMERS)(CAS DataBase Reference)
• NIST Chemistry Reference: FARNESYL BROMIDE, 95% (MIXED ISOMERS)(6874-67-5)
• EPA Substance Registry System: FARNESYL BROMIDE, 95% (MIXED ISOMERS)(6874-67-5)

Safety Data

• Hazardous Substances Data: 6874-67-5(Hazardous Substances Data)

Upstream product

• 7212-44-4 (+/-)-nerolidol 
• 1119-38-6 (S)-(+)-nerolidol 
• 4602-84-0 farnesol 
• 110-86-1 pyridine 
• 7789-60-8 phosphorus tribromide 
• 506-68-3 bromocyane 
• 108354-14-9 aurachin C 
• 106-28-5 Farnesol 
• 40716-66-3 (E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol 
• 19954-66-6 ethyl farnesoate 
• 25996-10-5 (Z)-neryl bromide 
• 71668-79-6 2(E),8(E)-Farnesyl mesylate 
• 37905-04-7 (2E,6E)-8-bromo-3,7-dimethylocta-2,6-dienyl acetate 
• 37905-03-6 8-hydroxygeranyl acetate 

Downstream Products

• 19317-11-4 farnesal 
• 502-67-0 Farnesal 
• 762-29-8 6,10,14-trimethyl-5,9,13-pentadecatrien-2-one 
• 111-02-4 squalene 
• 111-02-4 2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene 
• 16725-59-0 Diethyl-farnesylphenylmalonat 
• 103670-05-9 DL-2-Phenylglycin-farnesylester-hydrochlorid 
• 162520-00-5 2-(3,7,11-trimethyl-dodeca-2,6,10-trienylthio)-benzoic acid 
• 23224-49-9 5,9,13-trimethyl-tetradeca-4,8,12-trienoic acid 
• 141538-75-2 (6E,10E)-ethyl 7,11,15-trimethyl-3-oxohexadeca-6,10,14-trienoate 
• 103669-56-3 N-(2,3,4,5,6-Penta-O-acetyl-D-gluconoyl)-DL-2-phenylglycin-farnesylester 
• 2387-69-1 3,7,11,15-tetramethyl-hexadeca-6,10,14-trien-1-yn-3-ol 
• 68931-30-6 1,6,10,14-hexadecatetraen-3-ol, 3,7,11,15-tetramethyl- 
• 50848-64-1 2E,6E,10E-geranylgeranyl bromide 

Relevant articles and documents

Protein degradation targeting chimeric compound, preparation method and medical application thereof

The invention relates to a protein degradation targeting chimeric compound, a preparation method and medical application thereof, specifically to a compound as shown in a general formula (I), a preparation method of the compound, and application of the co

CHINONE-, HYDROCHINOME- AND NAPHTHOCHINONE-ANALOGUES OF VATIQUIONE FOR TREATMENT OF MITOCHONDRIAL DISORDER DISEASES

The disclosure provides therapeutic compositions (i.e., therapeutic agents) and methods of preventing or treating Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated with Friedreich's ataxia (e.g. Complex I deficiency), and/or reducing the likelihood or severity of Friedreich's ataxia. The disclosure further provides novel intermediates for the production of said therapeutic compositions and related reduced versions of said therapeutic compositions, which reduce forms may also be used as therapeutic agents (or prodrugs of the therapeutic agent(s)).

ANTIBIOTIC COMPOUNDS

Provided herein are lipidated glycopeptide compounds of formula (I); or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof. R1 is a lipid, R2 is -H or a lipid, and R3 and R4 are as defined herein. These compounds have antibiotic activity. Also provided are formulations comprising such compounds; as well as such compounds or formulations for use as a medicament. The compounds and formulations may also be used in the treatment of bacterial infection.